The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells

European Journal of Nutrition

Volumn 43, Issue 5, 2004, Pages 275-284

  Larrosa, Mar ^a   Tomás Barberán, Francisco A ^a   Espín, Juan Carlos ^a  

^a RESEARCH GROUP ON QUALITY   (Spain)

Author keywords

Apoptosis; Cancer; Cell cycle; Cell metabolite; Cyclin; Grape; Melanoma; Piceatannol; Polyphenol; SK Mel 28; Wine

Indexed keywords

3,5,3' TRIHYDROXY 4' METHOXYSTILBENE; 3,5,4' TRIHYDROXY 3' METHOXYSTILBENE; CYCLIN A; CYCLIN B1; CYCLIN E; PICEATANNOL; PROTEIN KINASE INHIBITOR; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DIETARY INTAKE; DRUG EXCRETION; DRUG POTENCY; EVALUATION; FLOW CYTOMETRY; GRAPE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INCUBATION TIME; LEUKEMIA; MELANOMA; MELANOMA CELL; WESTERN BLOTTING; WINE;

APOPTOSIS; CELL CYCLE; CELL DIVISION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FLOW CYTOMETRY; HUMANS; MELANOMA; STILBENES; TUMOR CELLS, CULTURED; VITIS; WINE;

ANIMALIA; VITACEAE; VITIS SP.;

EID: 5744234431     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00394-004-0471-5     Document Type: Article

References (44)

1. Inamori Y, Kato Y, Kubo M, Yasuda M, Baba K, Kozawa M (1984) Physiological activities of 3,3′-4,5′-tetrahydroxystilbene isolated from the heartwood of Cassia garrettiana CRAIB. Chem Pharm Bull (Tokyo) 32:213-218
2. Matsuda H, Kageura T, Morikawa T, Toguchida I, Harima S, Yoshikawa M (2000) Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages. Bioorg Med Chem Lett 10:323-327
3. Ferrigni NR, McLaughin JL, Powell RG, Smith CR (1984) Use of potato disc and brine shrimp bioassays to detect activity and isolate piceatannol as the antileukemic principle from the seeds of Euphorbia lagascae. J Nat Prod 47:347-352
4. Cantos E, Espin JC, Tomás-Barberán FA (2002) Postharvest stilbene-enrichment of red and white table grape varieties using UV-C irradiation pulses. J Agric Food Chem 50:6322-6329
5. Cantos E, Espín JC, Fernández MJ, Oliva J, Tomás-Barberán FA (2003) Postharvest UV-C irradiated grapes as potential source for producing stilbene-enriched red wines. J Agric Food Chem 51:1208-1214
6. Della Ragione F, Cucciolla V, Borriello A, Della Pietra V, Racioppi L, Soldati G, Manna C, Galletti P, Zappia V (1998) Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem Biophys Res Commun 250:53-58
7. Gusman J, Malonne H, Atassi G (2001) A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 22:1111-1117
8. Wolter F, Akoglu B, Clausnitzer A, Stein J (2001) Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J Nutr 131:2197-2203
9. Joe AK, Liu H, Suzui M, Vural ME, Xiao D, Weinstein IB (2002) Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 8:893-903
10. Larrosa M, Tomás-Barberán FA, Espín JC (2003) Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest and upregulation of cyclins A, E and B1 in human SK-Mel-28 melanoma cells. J Agric Food Chem 51:4576-4584
11. Potter GA, Patterson LH, Wanogho E, Perry PJ, Butler PC, Ijaz T, Ruparelia KC, Lamb JH, Farmer PB, Stanley LA, Burke MD (2002) The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br J Cancer 86:774-778
12. Geahlen RL, McLaughin JL (1989) Piceatannol (3,4,3′,5′- tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor. Biochem Biophys Res Commun 165:241-245
13. Seow CJ, Chue SC, Wong WS (2002) Piceatannol, a Syk-selective tyrosine kinase inhibitor, attenuated antigen challenge of guinea pig airways in vitro. Eur J Pharmacol 443:189-196
14. Fernández LA, Torrealba J, Yagci G, Ishido N, Tsuchida M, Tae Kim H, Dong Y, Oberley T, Fechner J, Colburn MJ, Shultz J, Kanmaz T, Hu H, Knechtle SJ, Hamawy MM (2002) Piceatannol in combination with low doses of cyclosporine A prolongs kidney allograft survival in a stringent rat transplantation model. Transplantation 74:1609-1617
15. Ashikawa K, Mjumdar S, Banerjee S, Bharti AC, Shishodia S, Aggarwal BB (2002) Piceatannol inhibits TNF-induced NF-κB activation and NF-κB-mediated gene expression through suppression of IκBα kinase and p65 phosphorilation. J Immunol 169:6490-6497
16. Wieder T, Prokop A, Bagci B, Essmann F, Bernicke D, Schulze-Osthoff K, Dörken B, Schmalz HG, Daniel PT, Henze G (2001) Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts. Leukemia 15:1735-1742
17. Wolter F, Clausnitzer A, Akoglu B, Stein J (2002) Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines. J Nutr 132:298-302
18. Hall HI, Miller DR, Rogers JD, Bewerse B (1999) Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 40:25-42
19. Bastuji-Garin S, Diepgen TL (2002) Cutaneous malignant melanoma, sun exposure, and sunscreen use: epidemiological evidence. Br J Dermatol 146:24-30
20. Gilchrest BA, Eller MS, Geller AC, Yaar M (1999) The pathogenesis of melanoma induced by ultraviolet radiation. New Engl J Med 340:1341-1348
21. Agarwala SS, Kirkwood JM (1998) Adjuvant interferon treatment for melanoma. Hematol Oncol Clin North Am 12:823-833
22. Keilholz U, Eggermont AM (2000) The emerging role of cytokines in the treatment of advanced melanoma. For the EORTC melanoma cooperative group. Oncology 58:89-95
23. Fu YM, Yu ZX, Ferrans VJ, Meadows GG (1997) Tyrosine and phenylalanine restriction induces G0/G1 cell cycle arrest in murine melanoma in vitro and in vivo. Nutr Cancer 29:104-113
24. Veierod MB, Thelle DS, Laake P (1997) Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Int J Cancer 71:600-604
25. Pozo-Guisado E, Á Alvarez-Barrientos A, Mulero-Navarro S, Santiago-Josefat B, Fernández-Salguero PM (2002) The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem Pharmacol 64:1375-1386
26. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal Biochem 210:727-735
27. Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S (1998) Chemopreventive agent resveratrol, a natural product derived from grapes triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92:996-1002
28. Bernhard D, Tinhofer I, Tonko M, Hübl H, Ausserlechner MJ, Grell R, Kofler R, Csordas A (2000) Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukaemia cells. Cell Death Diff 7:834-842
29. Ahmad N, Adhami VM, Afaq AF, Feyer DK, Mukhtar H (2001) Resveratrol causes WAF1/p21-mediated G1-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 7:1466-1473
30. Atten MJ, Attar BM, Milson R, Holian O (2001) Resveratrol-induced inactivation of human gastric adenocarcinoma cells through a protein kinase C-mediated mechanism. Biochem Pharmacol 62:1423-1432
31. Stivala LA, Savio M, Carafoli F, Perusca P, Bianchi L, Maga G, Forti L, Pagnoni UM, Albini A, Prosperi E, Vannini V (2001) Specific structural determinants are responsible for the antioxidant activity and cell cycle effects of resveratrol. J Biol Chem 276:22586-22594
32. Le NTV, Richardson DR (2002) The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta 1603:31-46
33. Pietenpol JA, Stewart ZA (2002) Cell cycle checkpoint signalling: cell cycle arrest versus apoptosis. Toxicology 181-182:475-481
34. Clifford B, Beljin M, Stark GR, Taylor WR (2003) G2 arrest in response to topoisomerase II inhibitors: the role of p53. Cancer Res 63:4074-4081
35. Verhagen H, Aruoma OI, van Delft JHM, Dragsted LR, Ferguson LR, Knasmüller S, Pool-Zobel BL, Poulsen HE, Williamson G, Yannai S (2003) The 10 basic requirements for a scientific paper reporting antioxidant, antimutagenic or anticarcinogenic potential of test substances in in vitro experiments and animal studies in vivo. Food Chem Toxicol 41:603-610
36. Scalbert A, Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130:2073S-2085S
37. Manach C (2003) The use of HPLC with coulometric array detection in the analysis of flavonoids in complex materials. In: Santos-Buelga C, Williamson G (eds) Methods in Polyphenol Analysis. The Royal Society of Chemistry, Cambridge, pp 61-91
38. Bohn BA (1998) Introduction to flavonoids. Harwood Academic Publishers, Amsterdam, p 195
39. Rechner AR, Kuhnle G, Bremner P, Hubbard GP, Moore KP, Rice-Evans CA (2002) The metabolic fate of dietary polyphenols in humans. Free Radic Biol Med 33:220-235
40. Caruso D, Visioli F, Patelli R, Galli C, Galli G (2001) Urinary excretion of olive oil phenols and their metabolites in humans. Metabolism 50:1426-1428
41. Manna C, Galletti P, Maisto G, Cucciolla V, D'Angello S, Zapia V (2000) Transport mechanism and metabolism of olive oil hydroxytyrosol in Caco2-cells. FEBS Lett 470:341-344
42. Moridani MY, Scobie H, O'Brien PJ (2002) Metabolism of caffeic acid by isolated rat hepatocytes and subcellular fractions. Toxicol Lett 133:141-151
43. Smit NP, Pavel S (1995) Induction of cytotoxicity in melanoma cells through inhibition of catechol-O-methyltransferase. Biochem Pharmacol 50:1955-1962
44. Morris GZ, Williams RL, Elliott MS, Beebe SJ (2002) Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells. Prostate 52:319-329